心理理论能力在稳定期精神分裂症精神症状与社会功能之间的中介作用

doi:10.3969/j.issn.1006-7795.2023.04.014

首都医科大学学报 ›› 2023, Vol. 44 ›› Issue (4): 590-595.doi: 10.3969/j.issn.1006-7795.2023.04.014

• 精神疾病中西医结合治疗 • 上一篇下一篇

心理理论能力在稳定期精神分裂症精神症状与社会功能之间的中介作用

仲捷^1，2，朱虹^1，2，郝军^1，2，贾竑晓^1，2*

1.首都医科大学附属北京安定医院国家精神心理疾病临床医学研究中心精神疾病诊断与治疗北京市重点实验室，北京100088； 2.首都医科大学人脑保护高精尖创新中心，北京 100069

收稿日期:2023-04-02 出版日期:2023-08-21 发布日期:2023-07-26
通讯作者: 贾竑晓 E-mail:jhxlj@ ccmu.edu.cn
基金资助:
北京市医院管理中心临床医学发展专项（ZYLX202129），北京市医院管理中心“登峰”人才培养计划项目（DFL20191901）

The mediating effect of theory of mind between psychotic symptoms and social functioning in stable schizophrenia

Zhong Jie^1，2, Zhu Hong^1，2, Hao Jun^1，2, Jia Hongxiao^1，2*

1. The National Clinical Research Center for Mental Disorders & Beijing Key Laboratory of Mental Disorders，Beijing Anding Hospital，Capital Medical University，Beijing 100088，China; 2. Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing 100069, China

Received:2023-04-02 Online:2023-08-21 Published:2023-07-26
Supported by:
This study was supported by Beijing Hospitals Authority Clinical Medicine Development of Special Funding Support （ZYLX202129），Beijing Hospitals Authority’s Ascent Plan（DFL20191901）.

摘要/Abstract

摘要： 目的探讨稳定期精神分裂症患者的心理理论能力在精神症状与社会功能之间的中介作用。方法选用阳性和阴性症状量表(Positive and Negative Syndrome Scale, PANSS)评估稳定期精神分裂症患者的精神症状；选取3种测试评估患者的神经认知功能：威斯康星卡片分类测验中的完成分类数、持续性操作测验平均反应时间、韦氏成人智力量表中的数字广度项目；选取4个心理理论能力任务评估患者的社会认知：一级错误信念、二级错误信念、失言识别任务和眼区阅读测试；选用个人与社会功能量表(Personal and Social Functioning Scale，PSP)评估精神分裂症患者的社会功能。分析稳定期精神分裂症患者的心理理论能力在精神症状与社会功能之间的中介效应。结果 PSP结果分别与患者的阴性症状呈负相关(r=－0.453, P<0.001)、与失言任务评分呈正相关(r=0.544, P=0.010)，失言任务评分与阴性症状呈负相关(r=－0.331, P<0.001)，阴性症状对社会功能有直接效应(β=－0.467, t=－0.461, P<0.01)，失言任务在阴性症状和社会功能之间有一定的中介作用（β=0.410，t=3.529, P<0.01）。结论稳定期精神分裂症患者的社会功能损害与阴性症状及心理理论能力密切相关。失言任务在患者精神症状与社会功能间存在中介作用。

关键词: 精神分裂症, 认知功能, 社会功能, 中介作用

Abstract: Objective To investigate the mediating role of theory of mind between psychotic symptoms and social functioning in stable schizophrenia patients. Methods Positive and negative syndrome scale (PANSS) was applied to assess patients’ psychiatric symptoms. The number of completed categories on the Wisconsin Card Sorting Test (WCST), the mean response time on the Continuous Performance Test (CPT), and the breadth of numbers on the Wechsler Adult Intelligence Scale (WAIS) were used to assess the general cognitive function of the patients. Four theory of mind tasks were selected to assess patients’ social cognition: the first-order false belief, the second-order false belief, the faux-pas task, and the reading the mind in eyes test. The Personal and Social Functioning Scale (PSP) was selected to assess the social functioning of patients with schizophrenia. Results PSP scores were negatively correlated with patients’ negative symptoms (r＝－0.453, P<0.001), positively correlated with faux-pas task scores (r=0.544, P=0.010). The faux-pas task scores were negatively correlated with negative symptoms (r＝－0.331, P<0.001), and negative symptoms had a direct effect on social functioning (β＝－0.470, P<0.01). There was a mediating effect of the aphasia task (β=0.407, P<0.01). Conclusions Impairment of social functioning in patients with stable schizophrenia is closely related to negative symptoms and social cognition. The faux-pas task partially mediates patients’ psychiatric symptoms and social functioning.

Key words: schizophrenia, cognitive function, social function, mediation

中图分类号:

R749.3

仲捷, 朱虹, 郝军, 贾竑晓. 心理理论能力在稳定期精神分裂症精神症状与社会功能之间的中介作用[J]. 首都医科大学学报, 2023, 44(4): 590-595.

Zhong Jie, Zhu Hong, Hao Jun, Jia Hongxiao. The mediating effect of theory of mind between psychotic symptoms and social functioning in stable schizophrenia[J]. Journal of Capital Medical University, 2023, 44(4): 590-595.

参考文献

［1］ Sergi M, Green M, Widmark C, et al. Social cognition and neurocognition: effects of risperidone, olanzapine, and haloperidol［J］. Am J Psychiatry, 2007, 164(10): 1585-1592.
［2］ Lincoln T M, Mehl S, Kesting M L, et al. Negative symptoms and social cognition: identifying targets for psychological interventions［J］. Schizophr Bull, 2011, 37(Suppl 2): S23－S32.
［3］ Foussias G, Remington G. Negative symptoms in schizophrenia: avolition and Occam’s razor［J］. Schizophr Bull, 2010, 36(2): 359-369.
［4］ Fett A K J, Viechtbauer W, Dominguez M D G, et al. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis［J］. Neurosci Biobehav Rev, 2011, 35(3): 573-588.
［5］ Milev P, Ho B C, Arndt S, et al. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up［J］. Am J Psychiatry, 2005, 162(3): 495-506.
［6］ Zanello A, Curtis L, Badan B’ M, et al. Working memory impairments in first-episode psychosis and chronic schizophrenia［J］. Psychiatry Res, 2009, 165(1/2): 10-18.
［7］ Thibaudeau É, Cellard C, Turcotte M, et al. Functional impairments and theory of mind deficits in schizophrenia: a meta-analysis of the associations［J］. Schizophr Bull, 2021, 47(3): 695-711.
［8］ American Psychiatric Association. Diagnostic and statistical manual of mental disorders:DSM-Ⅳ［M］． 4th ed. Washington, D.C.: American Psychiatric Association， 1994.
［9］乔颖, 何燕玲, 赵靖平, 等. 个体和社会功能量表信效度研究［J］. 中国医药导报, 2012, 9(26): 11-14.
［10］张颖, 王若梅, 李刚. 精神分裂症认知功能损害的研究进展［J］. 中国慢性病预防与控制, 2021, 29(2): 158-160.
［11］ Mike L K, Guimond S, Kelly S, et al. Social cognition in early course of schizophrenia: exploratory factor analysis［J］. Psychiatry Res, 2019, 272: 737-743.
［12］ Mondragón-Maya A, Ramos-Mastache D, Román P D, et al. Social cognition in schizophrenia, unaffected relatives and ultra-high risk for psychosis: what do we currently know?［J］. Actas Esp Psiquiatr, 2017, 45(5): 218-226.
［13］ Mehta U M, Thirthalli J, Kumar C N, et al. Negative symptoms mediate the influence of theory of mind on functional status in schizophrenia［J］. Soc Psychiatry Psychiatr Epidemiol, 2014, 49(7): 1151-1156.
［14］ Mazza M, Pollice R, Pacitti F, et al. New evidence in theory of mind deficits in subjects with chronic schizophrenia and first episode: correlation with symptoms, neurocognition and social function［J］. Riv Psichiatr, 2012, 47(4): 327-336.
［15］ Ventura J, Ered A, Gretchen-Doorly D, et al. Theory of mind in the early course of schizophrenia: stability, symptom and neurocognitive correlates, and relationship with functioning［J］. Psychol Med, 2015, 45(10): 2031-2043.
［16］ Chen S Y, Liu Y X, Liu D, et al. The difference of social cognitive and neurocognitive performance between patients with schizophrenia at different stages and influencing factors［J］. Schizophr Res Cogn, 2021, 24: 100195.
［17］ Mizrahi R, Korostil M, Starkstein S E, et al. The effect of antipsychotic treatment on theory of mind［J］. Psychol Med, 2007, 37(4): 595-601.
［18］ Bürkner P C, Williams D R, Simmons T C, et al. Intranasal oxytocin may improve high-level social cognition in schizophrenia, but not social cognition or neurocognition in general: a multilevel bayesian meta-analysis［J］. Schizophr Bull, 2017, 43(6): 1291-1303.
［19］ Savina I, Beninger R J. Schizophrenic patients treated with clozapine or olanzapine perform better on theory of mind tasks than those treated with risperidone or typical antipsychotic medications［J］. Schizophr Res, 2007, 94(1/3): 128-138.
［20］ Zhong J, Zhu H, Yin D Q, et al. Paliperidone compared with haloperidol on the theory of mind tasks in schizophrenia: a pilot trial［J］. Neuropsychiatr Dis Treat, 2021, 17: 3683-3691.
［21］ Yeo H, Yoon S, Lee J, et al. A meta-analysis of the effects of social-cognitive training in schizophrenia: the role of treatment characteristics and study quality［J］. Br J Clin Psychol, 2022, 61(1): 37-57.
［22］ Yamada Y, Sueyoshi K, Yokoi Y, et al. Transcranial direct current stimulation on the left superior temporal sulcus improves social cognition in schizophrenia: an open-label study［J］. Front Psychiatry, 2022, 13: 862814.
［23］ Ventura J, Wood R C, Hellemann G S. Symptom domains and neurocognitive functioning can help differentiate social cognitive processes in schizophrenia: a meta-analysis［J］. Schizophr Bull, 2013, 39(1): 102-111.

[1]	王群松, 于海燕, 季向东, 李苗, 蒋怡烨. 电针对新型抗精神病药物所致代谢综合征的干预效果[J]. 首都医科大学学报, 2023, 44(4): 614-619.
[2]	李莉, 刘超猛, 任艳萍, 杨春林, 马辛. 改良电休克治疗首发精神分裂症的研究进展[J]. 首都医科大学学报, 2022, 43(2): 249-253.
[3]	郭城伟, 周娇娇, 冯媛, 杨蕴萍. 精神分裂症患者与正常人自尊水平的对照研究[J]. 首都医科大学学报, 2022, 43(2): 294-298.
[4]	宁艳哲, 朱虹, 宋楠, 郑思思, 李自艳, 李佳佳, 马睿, 贾竑晓. 石珍安神颗粒改善精神分裂症前驱期患者认知损害的临床观察[J]. 首都医科大学学报, 2021, 42(3): 404-407.
[5]	李自艳, 刘鑫子, 杜渐, 王昊, 杨秋莉, 贾竑晓. 双相情感障碍的中医五态人格特征初探[J]. 首都医科大学学报, 2021, 42(3): 408-411.
[6]	沙莎, 赵希希, 韩传亮, 彭兴, 张培, 董雯, 尹晶晶, 王长明. 精神分裂症静息态下alpha活动和认知水平的相关性[J]. 首都医科大学学报, 2021, 42(1): 117-124.
[7]	张颖, 王若梅, 李刚. 稳定期精神分裂症患者认知功能、情绪管理水平及其影响因素分析[J]. 首都医科大学学报, 2021, 42(1): 143-147.
[8]	刘鑫垚, 马超, 贾竑晓. 精神分裂症认知损害动物模型的研究现状[J]. 首都医科大学学报, 2020, 41(1): 50-54.
[9]	李雪, 朱虹, 房萌, 宁艳哲, 赵爽, 尹冬青. 腹针治疗非典型抗精神病药物所致肥胖的治疗效果观察[J]. 首都医科大学学报, 2020, 41(1): 75-79.
[10]	庄文旭, 张伟波, 朱有为, 朱益, 蔡军. 对精神分裂症躯体健康问题的生活方式干预[J]. 首都医科大学学报, 2019, 40(5): 698-702.
[11]	尹冬青, 黄芳, 赵安全, 王群松, 马雁冰, 陈进东, 李宝君, 都弘, 贾竑晓. 精神分裂症中医证候要素诊断量表初步研究[J]. 首都医科大学学报, 2018, 39(6): 821-827.
[12]	边志明, 王长明, 刘晨阳, 张秀军, 马辛. 精神分裂症患者冲突监测功能缺陷的事件相关电位研究[J]. 首都医科大学学报, 2018, 39(5): 625-629.
[13]	孙丛丛, 周丹娜, 宁芳平, 马良, 闫丽琼, 任艳萍, 马辛. 重复经颅磁刺激治疗难治性精神分裂症的增效作用研究[J]. 首都医科大学学报, 2018, 39(5): 641-645.
[14]	徐园园, 周菘, 朱虹, 耿海燕, 贾竑晓. 精神分裂症自知力与无意识自我面孔识别的关系[J]. 首都医科大学学报, 2018, 39(2): 209-212.
[15]	范玉, 杨宁波, 田晴, 朱秀强, 王传跃. 健康人群和慢性精神分裂症病人前脉冲抑制的影响因素[J]. 首都医科大学学报, 2017, 38(2): 178-185.

心理理论能力在稳定期精神分裂症精神症状与社会功能之间的中介作用

The mediating effect of theory of mind between psychotic symptoms and social functioning in stable schizophrenia

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价